Spetzler-Martin I级和II级动静脉畸形的立体定向放射外科治疗:国际立体定向放射外科学会(ISRS)实践指南
该指南基于符合PRISMA的系统综述(检索Medline、Embase和Scopus,1986-2018年),纳入8项研究共1102例I-II级动静脉畸形(AVM),其中836例(76%)为II级。SRS治疗后中位37个月闭塞884例(80%),中位68个月随访期间出血66例(6%),无出血完全闭塞达78%。指南认为SRS可能是I-II级AVM安全有效的治疗选择,可考虑作为一线治疗,尤其适用于深部或功能区病变。
要点
- SRS治疗I-II级AVM的中位37个月闭塞率为80%(884/1102),中位68个月随访出血率为6%(66/1102)。
- 无出血完全闭塞率为78%,其中II级AVM中82%(555/680)具有高危特征(功能区或深部引流)。
- SRS可考虑作为I-II级AVM的一线治疗,尤其适用于深部或功能区病变。
核心结论
- 关于I-II级AVM的SRS文献质量较低,限制了结果解读。
- 谨慎观察发现,SRS似乎是I-II级AVM安全有效的治疗,可考虑作为一线治疗,尤其适用于深部或功能区病变。
- 既往发表文献可能受选择偏倚影响,有利的AVM接受切除,而并发症和不闭塞风险较高的病变更倾向于转诊至SRS。
研究设计与样本
- 国际立体定向放射外科学会(ISRS)基于符合PRISMA的系统综述制定实践指南,检索Medline、Embase和Scopus(1986-2018年)。
- 纳入标准为报告≥10例I-II级AVM SRS后结局且随访≥24个月的研究,共纳入8项研究(1项2级证据,7项4级证据),代表1102例AVM。
- 主要终点为闭塞和出血,次要结局包括Spetzler-Martin参数、剂量学变量和「优良」结局(完全闭塞且无新发SRS后神经功能缺损)。
主要发现
- 1102例AVM中,836例(76%)为II级。
- 中位37个月时884例(80%)实现闭塞;中位68个月随访期间发生66例(6%)出血。
- 无出血完全闭塞率为78%。
- 836例II级AVM中,680例报告了Spetzler-Martin参数:377例位于功能区脑组织,178例有深部静脉引流,共555/680(82%)为高危SRS治疗的II级AVM。
关键数值与推荐
- SRS可考虑作为I-II级AVM的一线治疗,尤其适用于深部或功能区病变(作者基于低质量文献的谨慎观察)。
临床怎么用
- 作者认为,SRS可考虑作为I-II级AVM的一线治疗,尤其适用于深部或功能区病变。
局限性
- 关于I-II级AVM的SRS文献质量较低,限制了结果解读。
- 既往发表文献可能受选择偏倚影响,有利的AVM接受切除,而并发症和不闭塞风险较高的病变更倾向于转诊至SRS。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: No guidelines have been published regarding stereotactic radiosurgery (SRS) in the management of Spetzler-Martin grade I and II arteriovenous malformations (AVMs). OBJECTIVE: To establish SRS practice guidelines for grade I-II AVMs on the basis of a systematic literature review. METHODS: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-compliant search of Medline, Embase, and Scopus, 1986-2018, for publications reporting post-SRS outcomes in ≥10 grade I-II AVMs with a follow-up of ≥24 mo. Primary endpoints were obliteration and hemorrhage; secondary outcomes included Spetzler-Martin parameters, dosimetric variables, and "excellent" outcomes (defined as total obliteration without new post-SRS deficit). RESULTS: Of 447 abstracts screened, 8 were included (n = 1, level 2 evidence; n = 7, level 4 evidence), representing 1102 AVMs, of which 836 (76%) were grade II. Obliteration was achieved in 884 (80%) at a median of 37 mo; 66 hemorrhages (6%) occurred during a median follow-up of 68 mo. Total obliteration without hemorrhage was achieved in 78%. Of 836 grade II AVMs, Spetzler-Martin parameters were reported in 680: 377 were eloquent brain and 178 had deep venous drainage, totaling 555/680 (82%) high-risk SRS-treated grade II AVMs. CONCLUSION: The literature regarding SRS for grade I-II AVM is low quality, limiting interpretation. Cautiously, we observed that SRS appears to be a safe, effective treatment for grade I-II AVM and may be considered a front-line treatment, particularly for lesions in deep or eloquent locations. Preceding publications may be influenced by selection bias, with favorable AVMs undergoing resection, whereas those at increased risk of complications and nonobliteration are disproportionately referred for SRS.
引用
- Graffeo CS, Sahgal A, De Salles A, et al. Stereotactic Radiosurgery for Spetzler-Martin Grade I and II Arteriovenous Malformations: International Society of Stereotactic Radiosurgery (ISRS) Practice Guideline. Neurosurgery. 2020. PMID: 32065836. doi:10.1093/neuros/nyaa004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。